Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007

Transfusion Medicine

Volumn 19, Issue 4, 2009, Pages 189-194

  Kafi Abad, S Amini ^a,b   Rezvan, H ^b   Abolghasemi, H ^c  

^a Department of Immunohematology ^*

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donor; HBsAg; Iran; Prevalence; Trend

Indexed keywords

BLOOD GROUP B ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; DONOR SELECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IRAN; MONITORING; NONHUMAN; POPULATION; SCREENING TEST; SEROLOGY; VASCULARIZATION;

BIOLOGICAL MARKERS; BLOOD DONORS; DONOR SELECTION; FEMALE; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 69249199376     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2009.00935.x     Document Type: Article

References (35)

1. Abolghasemi, H., Amid, A., Zeinali, S., Radfar, M.H., Eshaghi, P., Rahiminejad, M.S., Ehsani, M.A., Najmabadi, H., Akbari, M.T., Afrasiabi A., Akhavan-Niaki H., Hoorfar H. (2007) Thalassemia in Iran: epidemiology, prevention, and management. Journal of Pediatric Hematology/Oncology, 29, 233 238.
2. Alavian, S.M., Fallahian, F. & Lankarani, K.M. (2007) The changing epidemiology of hepatitis B in Iran. Journal of Gastrointestinal and Liver Diseases, 16, 403 406.
3. Alter, M.J., Kruszon-Moran, D., Nainan, O.V., McQuillan, G.M., Gao, F., Moyer, L.A., Kaslow, R.A., Margolis, H.S. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England Journal of Medicine, 341, 556 562.
4. Ameen, R., Sanad, N., Al-Shemmari, S., Siddique, I., Chowdhury, R.I., Al-Hamdan, S. & Al-Bashir, A. (2005) Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion, 45, 1973 1980.
5. Amini Kafi-abad, S., Shariati, M., Moghaddam, M. & Talebian A. (2007) Confidential unit exclusion process and blood safety: the Iranian blood transfusion organization experience between March 2004 and September 2006. Vox Sanguinis, 93 (Suppl. 1), 115.
6. Andre, F. (2000) Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine, 18 (Suppl. 1), S20 S22.
7. Bashawari, L.A., Fawaz, N.A., Ahmad, M.S., Qadi, A.A. & Almawi, W.Y. (2004) Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clinical and Laboratory Haematology, 26, 225 228.
8. Benvegnu, L., Fattovich, G., Noventa, F., Tremolada, F., Chemello, L., Cecchetto, A. & Alberti A. (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis, a prospective study. Cancer, 74, 2442 2448.
9. Bhattacharya, P., Chandra, P.K., Datta, S., Banerjee, A., Chakraborty, S., Rajendran, K., Basu, S.K., Bhattacharya, S.K., Chakravarty, R. (2007) Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bangal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World Journal of Gastroenterology, 13, 3730 3733.
10. Centers for Disease Control and Prevention (CDC). (2008) Yellow Book. Chapter 4: Prevention of specific infectious diseases - Hepatitis, Viral, Type B. [WWW document] URL http://wwwn.cdc.gov/travel/yellowbook/2008/ch4/hep-b.aspx.
11. Comanor, L. & Holland, P. (2006) Hepatitis B virus blood screening: unfinished agendas. Vox Sanguinis, 91, 1 12.
12. Dodd, R.Y., Notari, E.P. & Stramer, S.L. (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42, 975 979.
13. Glynn, S.A., Kleinman, S.H., Schreiber, G.B., Busch, M.P., Wright, D.J., Smith, J.W., Nass, C.C. & Williams, A.E. (2000) Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA, 284, 229 235.
14. Gurol, E., Saban, C., Oral, O., Cigdem, A. & Armagan, A. (2006) Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. European Journal of Epidemiology, 21, 299 305.
15. Irani-Hakime, N., Musharrafieh, U., Samaha, H. & Almawi, W.Y. (2006) Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003. American Journal of Infection Control, 34, 241 243.
16. Kaklamanti, E., Trichopoulos, D., Tzonou, A., Zavitsanos, X., Koumantaki, Y., Hatzakis, A., Hsieh, C.C. & Hatziyannis S. (1991) Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA, 265, 1974 1976.
17. Khattak, M.F., Salamat, N., Bhatti, F.A. & Qureshi, T.Z. (2002) Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. Journal of the Pakistan Medical Association, 52, 398 402.
18. Matee, M.I.N., Magesa, P.M., & Lyamuya, E.F. (2006) Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Salaam, Tanzania. BMC Public Health, 6, 21.
19. Malekzadeh, R., Khatibian, M. & Rezvan, H. (1997) Viral hepatitis in the world and Iran. Journal of Medical Council of Islamic Republic of Iran, 15, 183 200.
20. Massarrat, M.S. & Tahaghoghi-Mehrizi, S. (2002) Iranian national health survey: a brief report. Archives of Iranian Medicine, 5, 73 79.
21. Nantachit, N., Robison, V., Wongthanee, A., Kamtorn, N., Suriyanon, V. & Nelson, K.E. (2003) Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001. Transfusion, 43, 730 735.
22. Nanu, A., Sharma, S.P., Chatterjee, K. & Jyoti, P. (1997) Markers for transfusion-transmissible infections in North India voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sanguinis, 73, 70 73.
23. Offergeld, R., Faensen, D., Ritter, S. & Hamouda, O. (2005) Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveillance, 10, 8 11.
24. Pahuja, S., Sharma, M., Baitha, B. & Jain, M. (2007) Prevalence and trends of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Japanese Journal of Infectious Diseases, 60, 389 391.
25. Rezvan, H., Abolghasemi, H., & Amini Kafiabad, S. (2007) Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfusion Medicine, 17, 425 433.
26. Rosini, N., Mousse, D., Spada, C. & Treitinger, A. (2003) Seroprevalence of HBsAg, anti-HBc and anti-HCV in southern Brazil, 1999-2001. Brazilian Journal of Infectious Diseases, 7, 262 267.
27. Sallam, T.A., Tong, C.Y., Cuevas, L.E., Raja'a, Y.A., Othman, A.M. & Al-Kharsa, K.R. (2003) Prevalence of blood-borne viral hepatitis in different communities in Yemen. Epidemiology and Infection, 131, 771 775.
28. Sarkodie, F., Adarkwa, M., Adu-Sarkodie, Y., Candotti, D., Acheampong, J.W. & Allain, J.P. (2001) Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sanguinis, 80, 142 147.
29. Schmunis, G.A. & Cruz, J.R. (2005) Safety of the blood supply in Latin America. Clinical Microbiology Reviews, 18, 12 29.
30. Shang, G., Seed, C.R., Wang, F., Nie, D. & Farrugia, A. (2007) Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion, 47, 529 539.
31. Singh, B., Verma, M. & Verma, K. (2004) Markers for transfusion-associated hepatitis in North India blood donors: prevalence and trends. Japanese Journal of Infectious Diseases, 57, 49 51.
32. Soldan, K., Barbara, J.A.J., & Dow, B.C. (2002) Transfusion- transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sanguinis, 83, 305 308.
33. Soldan, K., Barbara, J.A., Ramsay, M.E. & Hall, A.J. (2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sanguinis, 84, 274 286.
34. Soldan, K., Davison, K. & Dow, B. (2005) Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveillance, 10, 17 19.
35. Zou, S.H., Notari, E.P., Stramer, S.L., Wahab, F., Musavi, F. & Dodd, R.Y. (2004) Pattern of age- and sex-specific prevalence of major blood- borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion, 44, 1640 1647.